Globus Medical, Inc. (NYSE:GMED) Receives $97.09 Consensus PT from Brokerages
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price target among brokerages […]
Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month price target among brokerages […]
